Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate.
boolean
C0007112 (UMLS CUI [1])
Prostate carcinoma Localized TNM clinical staging
Item
clinically localized prostate cancer: t1-2, nx or n0, mx or m0.
boolean
C0600139 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Absence Prior Therapy Prostate carcinoma | Prior Hormone Therapy Absent | Prior radiation therapy Absent | Operative Surgical Procedures Absent | Prior Chemotherapy Absent
Item
no previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
boolean
C0332197 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C1514460 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0279134 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0543467 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C1514457 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
ECOG performance status
Item
ecog performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Election Surveillance Prostate carcinoma
Item
patient has elected active surveillance as preferred management plan for prostate cancer.
boolean
C1707391 (UMLS CUI [1,1])
C0733511 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
Consent Acquisition Research Specimen
Item
patient consent has been obtained according to local institutional review board for acquisition of research specimens.
boolean
C1511481 (UMLS CUI [1,1])
C1706701 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
Patient Available Follow-up | Compliance behavior Follow-up
Item
patient is accessible and compliant for follow-up.
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C1321605 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
Biopsy of prostate Criteria
Item
prostate biopsy requirements:
boolean
C0194804 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Biopsy Quantity | Core needle biopsy Quantity
Item
1. if diagnosis was within one year of baseline visit, participant must have at least one biopsy with at least 10 cores.
boolean
C0005558 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1318309 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Prior diagnosis | Biopsy Quantity Minimum
Item
2. if diagnosis was more than 1 year prior to baseline visit, participant must have a minimum of 2 biopsies, one of which must be within 2 years prior to baseline visit.
boolean
C0332132 (UMLS CUI [1])
C0005558 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1524031 (UMLS CUI [2,3])
Series Biopsy of prostate Unwilling | Series Biopsy of prostate Unable
Item
unwillingness or inability to undergo serial prostate biopsy.
boolean
C0205549 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0205549 (UMLS CUI [2,1])
C0194804 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Cancer Other | Exception Skin carcinoma Treated | Exception Superficial bladder cancer Treated | Exception Curative treatment Solid Neoplasm | Exception Disease Free of
Item
history of other malignancies, except: adequately treated non-melanoma skin cancer or adequately treated superficial bladder cancer (ta) or other solid tumors curatively treated with no evidence of disease for > 5 years.
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1336527 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0280100 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0012634 (UMLS CUI [5,2])
C0332296 (UMLS CUI [5,3])